Victory Capital Management
APLT

Victory Capital Management’s Applied Therapeutics APLT Stock Holding History

Victory Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,103
Closed -$5.43K – 2480
2025
Q1 		$5.43K Buy
11,103
+309
+3% +$182 ﹤0.01% 2467
2024
Q4 		$9.24K Sell
10,794
-358
-3% -$2.24K ﹤0.01% 2468
2024
Q3 		$94.8K Sell
11,152
-342
-3% -$2.02K ﹤0.01% 2330
2024
Q2 		$53.7K Buy
+11,494
New +$54.4K ﹤0.01% 2359
2020
Q3 		– Sell
-6,585
Closed -$238K – 2494
2020
Q2 		$238K Buy
6,585
+2,015
+44% +$84.3K ﹤0.01% 2250
2020
Q1 		$150K Buy
+4,570
New +$185K ﹤0.01% 2407
2019
Q4 		– Sell
-706
Closed -$8K – 2662
2019
Q3 		$8K Buy
+706
New +$6.66K ﹤0.01% 3321

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Victory Capital Management's APLT Position: Q2 2025 in Review

Victory Capital Management sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 11,103 shares — an estimated $5.43K sold.

Victory Capital Management first reported a position in APLT in Q3 2019 and held it in 7 quarters. The position peaked at $238K in Q2 2020. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Victory Capital Management reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Victory Capital Management sold 11,103 Applied Therapeutics shares in Q2 2025, an estimated $5.43K.
  • Victory Capital Management first reported a position in Applied Therapeutics in Q3 2019 and held it in 7 quarters.
  • Victory Capital Management's Applied Therapeutics position peaked at $238K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Victory Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.